Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endurant CHevAr New Indication Trial: ENCHANT - Post-market Study of the Endurant CHEVAR Technique for the Treatment of Juxtarenal Aortic Aneurysms With a Short Infrarenal Neck

NCT03320252 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT03320252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03320252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endurant CHevAr New Indication Trial: ENCHANT - Post-market Study of the Endurant CHEVAR Technique for the Treatment of Juxtarenal Aortic Aneurysms With a Short Infrarenal Neck
Lead sponsor
Medtronic Cardiovascular
Phase
Observational
Overall status
Active, not recruiting
Start date
October 26, 2017
Completion date
July 31, 2030
Enrollment
150 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

aaa - abdominal aortic aneurysm